Ustekinumab is used to treat inflammatory types of arthritis, such as psoriatic arthritis (PsA), by blocking inflammatory proteins interleukin-12 and 23 (IL-12, IL-23). It can help suppress an overactive immune system, but can also increase your risk for certain infections. There are biosimilar versions of ustekinumab, which are highly similar versions of the drug which have the same clinical efficacy and safety compared with the originator biologic drug.
This information was last updated in June 2024 with expert review and advice by:
Alan Low, BSc(Pharm), PharmD, ACPR, FCSHP, CCD, RPh
Clinical Professor, Faculty of Pharmaceutical Sciences, University of British Columbia
Pharmacy Lead and Primary Care Pharmacist, BioPro Biologics Pharmacy
Care Director, MedInfuse Health
Garrett Tang, PharmD, RPh
Pharmacist Services Coordinator, MedInfuse Health
We also thank previous expert contributor:
Jason Kielly, BSc(Pharm), PharmD
Assistant Professor, School of Pharmacy, Memorial University of Newfoundland
Clinical Pharmacist, Rheumatic Health Program, Eastern Health
Go Back to Drug Index
Share